Yaowaluck Hongkaew

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next-Generation Sequencing for Routine Clinical Practice.

Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next-Generation Sequencing for Routine Clinical Practice.

Journal: Clinical and translational science

Published: June 13, 2025

A precision medicine approach to personalized prescribing using genetic and nongenetic factors for clinical decision-making.

A precision medicine approach to personalized prescribing using genetic and nongenetic factors for clinical decision-making.

Journal: Computers in biology and medicine

Published: June 06, 2023

Association of UGT1A16, UGT1A128, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis.

Association of UGT1A16, UGT1A128, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis.

Journal: Clinical and translational science

Published: November 30, 2021

Associations of the SREBF2 Gene and INSIG2 Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone.

Associations of the SREBF2 Gene and INSIG2 Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone.

Journal: Journal of personalized medicine

Published: August 08, 2021

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder.

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder.

Journal: Frontiers in pharmacology

Published: July 18, 2021

Resolving discordant CYP2D6 genotyping results in Thai subjects: platform limitations and novel haplotypes.

Resolving discordant CYP2D6 genotyping results in Thai subjects: platform limitations and novel haplotypes.

Journal: Pharmacogenomics

Published: May 17, 2021

Effect of 5-HT2C receptor gene polymorphism (HTR2C-759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone.

Effect of 5-HT2C receptor gene polymorphism (HTR2C-759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone.

Journal: Pharmacoepidemiology and drug safety

Published: March 02, 2021

Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone.

Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone.

Journal: Scientific reports

Published: October 13, 2020

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors.

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors.

Journal: Frontiers in pharmacology

Published: May 23, 2020

CYP2D6 genotype analysis of a Thai population: platform comparison.

CYP2D6 genotype analysis of a Thai population: platform comparison.

Journal: Pharmacogenomics

Published: July 12, 2018

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder.

UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder.

Journal: The pharmacogenomics journal

Published: September 15, 2017

Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder.

Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder.

Journal: Basic & clinical pharmacology & toxicology

Published: September 14, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026